Quviviq

Active Ingredient(s): Daridorexant
FDA Approved: * January 7, 2022
Pharm Company: * IDORSIA PHARMACEUTICALS LTD.
Category: Sleep Aid

Daridorexant, sold under the brand name Quviviq, is a medication used for the treatment of insomnia.[1] Daridorexant is a dual orexin receptor antagonist (DORA) which was originated by Actelion Pharmaceuticals and is under development by Idorsia Pharmaceuticals.[3][4] It acts as a selective dual antagonist of the orexin receptors OX1 and OX2.[3][4] The medication has a relatively short elimination half-life of 6 t... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Quviviq 25 mg Oral Tablet, Film Coated
NDC: 80491-7825
Labeler:
Idorsia Pharmaceuticals Ltd
Quviviq 50 mg Oral Tablet, Film Coated
NDC: 80491-7850
Labeler:
Idorsia Pharmaceuticals Ltd